Over-expression of HER2 in Indian patients with gastric cancer

被引:0
作者
Prachi S. Patil
Shaesta A. Mehta
K. M. Mohandas
机构
[1] Tata Memorial Hospital,Department of Digestive Diseases and Clinical Nutrition
关键词
Gastric Cancer; Trastuzumab; Tyrosine Kinase Inhibitor; Advanced Gastric Cancer; Gastric Cancer Tissue;
D O I
10.1007/s12664-012-0279-9
中图分类号
学科分类号
摘要
引用
收藏
页码:350 / 350
相关论文
共 11 条
  • [1] Bang YJ(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet. 376 687-97
  • [2] Van Cutsem E(2012)HER2 expression in gastric cancer in Indian population—an immunohistochemistry and fluorescence in situ hybridization study Indian J Gastroenterol. 31 106-10
  • [3] Feyereislova A(2012)Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes—a systematic review Int J Cancer. 130 2845-56
  • [4] Sekaran A(2009)Registry of gastric cancer treatment evaluation (REGATE): Baseline characteristics of 10,299 patients from 22 countries J Clin Oncol 27 4575-undefined
  • [5] Kandagaddala RS(undefined)undefined undefined undefined undefined-undefined
  • [6] Darisetty S(undefined)undefined undefined undefined undefined-undefined
  • [7] Chua TC(undefined)undefined undefined undefined undefined-undefined
  • [8] Merrett ND(undefined)undefined undefined undefined undefined-undefined
  • [9] Ter-Ovanesov MD(undefined)undefined undefined undefined undefined-undefined
  • [10] Bang Y(undefined)undefined undefined undefined undefined-undefined